Markets:

Overview

News

Currencies

International

Treasuries

Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

17.36 -0.28 (-1.59%)

Streaming Delayed Price Updated: 3:08 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Limited - American Depositary Shares

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in China’s National Reimbursement Drug List

January 18, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Appoints Michel Vounatsos To Its Board of Directors

January 09, 2023

From Zai Lab Limited

Via GlobeNewswire

Stock Market Mostly Higher Amid Jobs Report; Tesla Price Cuts, GE Spinoff In Focus: Weekly Review ↗

January 06, 2023

The major indexes rallied Friday on the jobs report and services data.

Via Investor's Business Daily

What's Going On With Zai Lab Stock ↗

January 04, 2023

Zai Lab Ltd - ADR (NASDAQ: ZLAB) shares are trading higher by 7.04% to $33.01 Wednesday morning.

Via Benzinga

Why Shares of Zai Lab Soared This Week ↗

January 05, 2023

A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.

Via The Motley Fool

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 05, 2023

Via Benzinga

Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients ↗

January 05, 2023

Via Benzinga

This Good News on Cancer Sent 2 Nasdaq Stocks Soaring ↗

January 05, 2023

Biotech investors are optimistic about the prospects for a potential treatment.

Via The Motley Fool

US Stocks Open Lower; Dow Tumbles 300 Points ↗

January 05, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 05, 2023

Via Benzinga

Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

January 05, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development

January 03, 2023

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces Participation in January Investor Conferences

December 20, 2022

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Phase 3 Study at the ESMO Virtual Plenary

December 15, 2022

From Zai Lab Limited

Via GlobeNewswire

Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket ↗

December 09, 2022

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients...

Via Benzinga

Broadcom, DocuSign And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

December 09, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

December 05, 2022

From Zai Lab Limited

Via GlobeNewswire

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors ↗

December 02, 2022

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.

Via Benzinga

Chinese Stocks Are Surging Today: What's Going On? ↗

November 29, 2022

Shares of several Chinese companies are trading higher Tuesday amid hopes that protests in China could spark an easing of COVID restrictions.

Via Benzinga

Unity Software, Amazon, Doximity And Other Big Gainers From Friday ↗

November 14, 2022

U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗

November 14, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.

Via Benzinga

Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session ↗

November 11, 2022

Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.

Via Benzinga

Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates

November 09, 2022

From Zai Lab Limited

Via GlobeNewswire

Earnings Scheduled For November 9, 2022 ↗

November 09, 2022

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.

Via Benzinga

Zai Lab Earnings Preview ↗

November 08, 2022

Zai Lab (NASDAQ:ZLAB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Zai Lab will...

Via Benzinga

Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer Annual Meeting

November 08, 2022

Poster presentations will highlight Zai’s key internal pipeline programs, ZL-1211 (anti-CLDN18.2 antibody) for gastric cancer and ZL-1218 (anti-CCR8 antibody) for solid tumors

From Zai Lab Limited

Via GlobeNewswire

Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer

November 08, 2022

From Zai Lab Limited

Via GlobeNewswire

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗

November 03, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.